GlassScriptPhysician profile
Molly Ann Carroll
NPI 1144549262
$1,210.46
in general payments reported to CMS, 2019-2025
18 companies · $43.67 in 2025
The $43.67 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $348 · 2020: $20.87 · 2021: $233 · 2022: $273 · 2023: $164 · 2024: $128 · 2025: $43.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $336.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $335.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $208.02 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $201.45 | 2022-2023 | Lynparza |
| Caldera Medical, INC | $131.98 | 2019 | |
| Acessa Health INC. | $126.60 | 2019 | |
| Boston Scientific Corporation | $111.97 | 2024 | |
| Genmab U.S., INC. | $92.93 | 2022 | |
| Eisai INC. | $47.75 | 2022-2023 | |
| Astellas Pharma US INC | $43.67 | 2025 | Veozah |
| Abbvie INC. | $42.40 | 2019 | |
| Therapeuticsmd, INC. | $36.79 | 2019-2020 | |
| Amneal Pharmaceuticals LLC | $33.80 | 2023 | Neulasta, Neupogen, Avastin |
| Minerva Surgical, INC | $31.08 | 2019 | |
| Coopersurgical, INC. | $28.20 | 2021-2024 | Paragard T 380a |
| Daiichi Sankyo INC. | $22.11 | 2022 | |
| Hologic Sales and Service, LLC | $16.44 | 2023 | Aptima |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12.77 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.77 | 2022 | |
| Organon LLC | $10.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Molly Carroll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.